You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
The Attain Command™ + SureValve™ left-heart delivery system is intended for introducing transvenous devices and leads into vessels of the left heart via the coronary sinus.
The Attain Select II + SureValve delivery catheter system is indicated for the delivery of contrast medium and transvenous devices to the coronary sinus and left-heart venous anatomy. The delivery catheter system is indicated for use with outer guide catheters.
For Attain Command + SureValve left-heart delivery system, if the patient has obstructed or inadequate vasculature, for either venous access or in the coronary sinus, the left-heart delivery system is contraindicated.
For Attain Select II + SureValve delivery catheter system, use of the delivery catheter system is contraindicated in patients with obstructed or inadequate vasculature.
The delivery catheter system is for single use only and is not intended to be resterilised.
Use the delivery catheter system only with compatible transvenous devices. No test data is available to demonstrate compatibility of the catheters with any device that is not manufactured or distributed by Medtronic. Consequences of using the catheters with incompatible devices may include the inability to deliver the transvenous device or damage to the transvenous device during delivery.
Handle the catheters with care at all times. Do not kink, stretch, or severely bend the catheters. Do not use surgical instruments to grasp the catheter shaft. Do not use excessive force when inserting a catheter into a vessel. Ensure that the catheters are thoroughly flushed with saline or heparinised saline and free of air before use to avoid air embolism to the patient. Do not allow the catheter to come into contact with liquids other than blood, saline, or contrast solution.
Use care when passing a catheter through vessels and tissue. To minimise risk of perforation and dissection, do not push, pull, or rotate the catheter against resistance. If resistance is met, discontinue movement, determine the reason for resistance, and take appropriate action before continuing. Damage to the catheter may prevent it from performing with accurate torque response and control.
Flush the catheters through the proximal end of the catheter. The catheters must be thoroughly flushed and free of air before use. Do not use a power injection syringe to inject contrast solution.
Keep external defibrillation equipment nearby for immediate use during insertion, placement, acute lead system testing, or whenever arrhythmias are possible or intentionally induced. Backup pacing should be readily available during implant. For information about potential adverse events or complications, refer to the product documentation packaged with the products chosen. Use of the catheters or transvenous devices may cause heart block.
Thrombogenicity evaluations were conducted using a heparinised model. If your patient cannot be adequately anticoagulated, it is unknown whether thrombus formation may occur with this product.
For Attain Command + SureValve left-heart delivery system, due to the relative stiffness of the catheter, damage to the walls of the vessels may include perforations or dissections. When in the right chamber of the heart, the guide-catheter dilator must be retracted within the outer guide catheter tip to minimise the risk of perforation.
Potential adverse events related to the use of the delivery catheter system include, but are not limited to, the following: air embolism, allergic reaction to contrast media, arteriovenous fistula formation, bleeding at the insertion site, brachial plexus injury, cardiac tamponade, dislodgement, dissection, endocarditis, heart block, hematoma formation, hemothorax, infection, irregular heart beat, mediastinal widening, perforation, pneumothorax, subclavian artery puncture, thrombophlebitis, thrombosis, valve damage, vascular occlusion, vessel damage.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
The deflectable catheter delivery system is indicated to provide a pathway through which diagnostic and therapeutic transvenous devices are introduced within the chambers and coronary vasculature of the heart, and for introducing balloon catheters into the coronary sinus or leads into vessels of the left heart via the coronary sinus.
Use of the deflectable catheter delivery system is contraindicated for right ventricular use in patients with tricuspid valvular disease or a mechanical tricuspid heart valve. Use of the deflectable catheter delivery system is contraindicated in patients with obstructed or inadequate vasculature.
The deflectable catheter delivery system is for single use only and is not intended to be resterilised.
Use the deflectable catheter only with compatible transvenous devices. No test data is available to demonstrate compatibility of the deflectable catheter with any device not manufactured by Medtronic. No test data is available to demonstrate compatibility of transvenous devices larger than 2.1 mm (6.2 French), with the exception of the 2.3 mm (7.0 French) deflectable catheter dilator included in this package. Consequences of using the deflectable catheter with incompatible devices may include the inability to deliver the transvenous device or damage to the transvenous device during delivery.
Handle the deflectable catheter with care at all times. Do not kink, stretch, or severely bend the deflectable catheter. Do not use surgical instruments to grasp the deflectable catheter. Do not use excessive force when inserting a deflectable catheter into a vessel. Do not wipe the deflectable catheter with chlorofluorocarbon-based solvents. Ensure the deflectable catheter is thoroughly flushed with saline and free of air prior to use to avoid air embolism to the patient. Avoid contact with liquids other than isopropyl alcohol, blood, saline, or contrast solution.
Use care when passing the deflectable catheter through vessels and tissue. Avoid damaging vessels and cardiac tissue, such as perforations and dissections, during deflectable catheter passage and positioning. Remove the dilator after the deflectable catheter assembly has been advanced into the right atrium to minimise the risk of perforation. Straighten the distal section as much as possible before removing the deflectable catheter from the patient to avoid vessel damage during removal.
Keep the cutting surface of the slitter in line with the hub and catheter shaft axis. Do not move the catheter or slitter in a back and forth motion. This ensures that the hub and guide catheter wall are cleanly slit by the slitter blade, preventing transvenous device damage and/or dislodgements.
Use the introducer valve to impede the backflow of venous blood during the implant procedure. Ensure that the side-port stopcock is closed before attaching the valve to the deflectable catheter hub. The side-port is for flushing the deflectable catheter only. Do not infuse through the side-port. When using the side-port, consider sealing the proximal opening of the introducer valve with a thumb or forefinger.
Use the side-port on the introducer valve to flush the deflectable catheter. The deflectable catheter must be thoroughly flushed and free of air prior to use. Do not use a power injection syringe to inject contrast solution.
Keep external defibrillation equipment nearby for immediate use during insertion, placement, acute lead system testing, or whenever arrhythmias are possible or intentionally induced. Backup pacing should be readily available during implant. Use of the deflectable catheter delivery system and/or transvenous devices may cause heart block.
Potential adverse events related to the use of the deflectable catheter may include, but are not limited to, the following events: air embolism, allergic reaction to contrast media, arteriovenous fistula formation, bleeding at the insertion site, brachial plexus injury, cardiac tamponade, dislodgement, dissection, endocarditis, heart block, hematoma formation, hemothorax, infection, irregular heart beat, mediastinal widening, perforation, pneumothorax, subclavian artery puncture, thrombophlebitis, thrombosis, valve damage, vascular occlusion, vessel damage.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
The venogram balloon catheter is indicated for use within the coronary sinus; it is intended for infusing contrast solutions into the coronary vasculature for venogram imaging.
The venogram balloon catheter is contraindicated for patients with a known allergy to latex or contrast medium.
Potential complications related to the use of the venogram balloon catheter include, but are not limited to, the following patient-related conditions: air embolism, allergic reaction to contrast media, allergic reaction to latex, arteriovenous fistula formation, bleeding at the insertion site, brachial plexus injury, cardiac tamponade, dissection, endocarditis, hematoma formation, hemothorax, infection, irregular heart beat, perforation, pneumothorax, subclavian artery puncture, thrombophlebitis, thrombosis, valve damage, vascular occlusion, vessel damage.
Other potential complications related to the venogram balloon catheter include, but are not limited to the following: balloon rupture, catheter knotting.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
The venogram balloon catheter is indicated for use within the coronary sinus; it is intended for infusing contrast solutions into the coronary vasculature for occlusive venogram imaging.
The venogram balloon catheter is contraindicated for patients with a known allergy to contrast medium.
Potential complications related to the use of the venogram balloon catheter include, but are not limited to, the following patient-related conditions: air embolism, allergic reaction to contrast media, bleeding at the insertion site, brachial plexus injury, cardiac tamponade, dissection, endocarditis, hematoma formation, hemothorax, infection, irregular heart beat, perforation, pneumothorax, subclavian artery puncture, thrombophlebitis, thrombosis, valve damage, vascular occlusion, vessel damage. Other potential complications related to the venogram balloon catheter include, but are not limited to the following: balloon rupture, catheter kinking.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
The Attain Hybrid™ guide wire is intended to aid in the placement of Medtronic transvenous left ventricular leads in the coronary vasculature.
The guide wire is not intended for use in the cerebral vasculature.
Potential complications related to the use of the guide wire include, but are not limited to, the following: air embolism, cardiac perforation, coronary sinus dissection, coronary sinus perforation, heart block.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
Use of these devices should be restricted to those specialists trained to perform the procedure. A thorough understanding of the technical principles, clinical applications, and associated risks is necessary before performing the procedure. Prior to use, please review the device instructions for use for detailed information regarding procedural instructions, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please consult the Medtronic website at www.medtronic.com.
Swan HNC, et al. N Engl J Med. 1970;283:447-451.